Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|
Total reported revenue | 8.8B | 5.9B | 5.0B |
Cost of revenue | 2.6B | 2.4B | 1.8B |
Gross profit | 6.2B | 3.5B | 3.2B |
Operating expense | |||
Research & development | — | — | — |
Selling general and admin | — | — | — |
Other operating expenses | — | — | — |
Operating income | 2.0B | 247M | 118M |
Non operating interest income | |||
Income | 0 | 0 | 0 |
Expense | 15M | 3M | 4M |
Other income expense | — | — | — |
Pretax income | 2.4B | 725M | 526M |
Tax provision | 879M | 228M | 139M |
Net income | 1.6B | 497M | 386M |
Basic EPS | — | 14.4 | — |
Diluted EPS | — | 14.3 | — |
Basic average shares | — | 32.4M | — |
Diluted average shares | — | 32.6M | — |
EBITDA | 2.5B | 726M | 530M |
Net income from continuing op. | — | — | — |
Minority interests | -23M | -30M | 3M |
Preferred stock dividends | 0 | 0 | 0 |